Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment (Q33423563)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment
scientific article

    Statements

    Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment (English)
    Lieven Baert
    Gerben van 't Klooster
    Marc François
    Alfons Wouters
    Esther Basstanie
    Koen Iterbeke
    Fred Stappers
    Paul Stevens
    Laurent Schueller
    Pieter Van Remoortere
    Guenter Kraus
    Piet Wigerinck

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit